Literature DB >> 22652786

Obesity and gastric cancer.

Qiang Li1, Jun Zhang, Yongning Zhou, Liang Qiao.   

Abstract

Obesity is an important public health problem worldwide. It increases the risk of many chronic diseases such as diabetes and cardiovascular diseases. Meanwhile, obesity is a major risk factor for several types of cancer including gastric cancer. Possible mechanisms linking obesity with gastric cancer may include obesity associated gastro-oesophageal reflux, insulin resistance, altered levels of adiponectin, leptin, ghrelin, and an abnormally increased blood level of insulin-like growth factor (IGF). Helicobacter pylori (H. pylori) infection is a well-recognized risk factor for peptic ulcer and gastric cancer. Recent studies have revealed an increased prevalence of H. pylori infection in obese patients, providing another clue for the increased incidence of gastric cancer in obese population. If this connection can be confirmed in animal models and a large cohort of patients, then eradicating H. pylori together with life style modification in obese individuals may help prevent the development of gastric cancer in the increasingly obese population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22652786     DOI: 10.2741/4059

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  10 in total

Review 1.  Obesity and cancer: A mechanistic overview of metabolic changes in obesity that impact genetic instability.

Authors:  Pallavi Kompella; Karen M Vasquez
Journal:  Mol Carcinog       Date:  2019-06-05       Impact factor: 4.784

Review 2.  Helicobacter pylori in gastric malignancies.

Authors:  Abhishek Bhandari; Sheila E Crowe
Journal:  Curr Gastroenterol Rep       Date:  2012-12

3.  Gastro-oesophageal reflux disease in type 2 diabetics: symptom load and pathophysiologic aspects - a retro-pro study.

Authors:  Regina Promberger; Johannes Lenglinger; Otto Riedl; Gernot Seebacher; Wolf Eilenberg; Johannes Ott; Franz Riegler; Michael Gadenstätter; Christoph Neumayer
Journal:  BMC Gastroenterol       Date:  2013-08-23       Impact factor: 3.067

4.  Association Study between Folate Pathway Gene Single Nucleotide Polymorphisms and Gastric Cancer in Koreans.

Authors:  Jae-Young Yoo; Sook-Young Kim; Jung-Ah Hwang; Seung-Hyun Hong; Aesun Shin; Il Ju Choi; Yeon-Su Lee
Journal:  Genomics Inform       Date:  2012-09-28

Review 5.  The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives.

Authors:  Bao Quoc Lam; Sushant K Shrivastava; Anju Shrivastava; Sharmila Shankar; Rakesh K Srivastava
Journal:  J Cell Mol Med       Date:  2020-05-26       Impact factor: 5.310

Review 6.  Curbing Lipids: Impacts ON Cancer and Viral Infection.

Authors:  Anika Dutta; Neelam Sharma-Walia
Journal:  Int J Mol Sci       Date:  2019-02-02       Impact factor: 5.923

Review 7.  The Role of Type 2 Diabetes in Pancreatic Cancer.

Authors:  Sheeba George; Wilford Jean-Baptiste; Amina Yusuf Ali; Bithaiah Inyang; Feeba Sam Koshy; Kitty George; Prakar Poudel; Roopa Chalasani; Mastiyage R Goonathilake; Sara Waqar; Lubna Mohammed
Journal:  Cureus       Date:  2022-06-24

8.  Sex Differences in All-Cause Inpatient Mortality Risk in Gastric Cancer: Nationwide Inpatient Population-Based Study.

Authors:  Sravani Kommuru; Yakub Ibrahim; Yash P Ashara; Karanpreet Singh; Maitri P Shah; Suchi D Shah; Trisha Saha
Journal:  Cureus       Date:  2022-08-30

9.  Inpatient burden of gastric cancer in the United States.

Authors:  Shantanu Solanki; Raja Chandra Chakinala; Khwaja Fahad Haq; Muhammad Ali Khan; Alina Kifayat; Katherine Linder; Zubair Khan; Uvesh Mansuri; Khwaja Saad Haq; Christopher Nabors; Wilbert S Aronow
Journal:  Ann Transl Med       Date:  2019-12

10.  A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort.

Authors:  Lei Huang; Zhi-Jian Wei; Tuan-Jie Li; Yu-Ming Jiang; A-Man Xu
Journal:  Oncotarget       Date:  2017-07-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.